Drug
Aleglitazar clinical trials
- studies test it
- 22
- open now
- 0
- in phase 3
- 8
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2012 (10)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 10 |
| 2013 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 6
- Phase 3
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 0
Often tested with
Tested in the same studies.
Metformin (1) · Digoxin (1) · Rifampin (1) · Ethinyl estradiol, levonorgestrel drug combination (1)
Studies
Open first, then newest update. How each study uses aleglitazar is read from its arms, and is right about nine times in ten.
Testing it · 22
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneCompletedPhase 3Hoffmann-La RocheNCT01691846Written as aleglitazar+metformin
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin TherapyCompletedPhase 3Hoffmann-La RocheNCT01691989Written as aleglitazar
- A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentCompletedPhase 2Hoffmann-La RocheNCT01043029Written as aleglitazar
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusCompletedPhase 3Hoffmann-La RocheNCT01042769Written as Aleglitazar
- A Study of Aleglitazar in Combination With Aspirin in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01188304Written as aleglitazar
- A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With LisinoprilCompletedPhase 1Hoffmann-La RocheNCT01398267Written as aleglitazar
- A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01701739Written as aleglitazar
- A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01679639Written as aleglitazar
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesCompletedPhase 3Hoffmann-La RocheNCT01715818Written as aleglitazar
- A Study of Aleglitazar in Patients With Type 2 DiabetesCompletedPhase 2Hoffmann-La RocheNCT00388518Written as aleglitazar
- A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With MetforminCompletedPhase 2Hoffmann-La RocheNCT01729403Written as aleglitazar
- A Pharmacokinetic Study of Aleglitazar in Healthy Chinese VolunteersCompletedPhase 1Hoffmann-La RocheNCT01711775Written as aleglitazar
- A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery DiseaseCompletedPhase 2Hoffmann-La RocheNCT01680978Written as aleglitazar
- A Study of Aleglitazar in Combination With Oral Contraceptive Healthy VolunteersCompletedPhase 1Hoffmann-La RocheNCT01615354Written as Aleglitazar
- A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic TherapyCompletedPhase 3Hoffmann-La RocheNCT01871428Written as aleglitazar
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin MonotherapyCompletedPhase 3Hoffmann-La RocheNCT01871415Written as aleglitazar
- A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)WithdrawnPhase 3Hoffmann-La RocheNCT01893242Written as Aleglitazar
- A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic TherapyCompletedPhase 3Hoffmann-La RocheNCT01691755Written as aleglitazar
- A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.CompletedPhase 2Hoffmann-La RocheNCT00461058Written as aleglitazar
- A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.CompletedPhase 2Hoffmann-La RocheNCT00461006Written as aleglitazar
Codes
What other systems call aleglitazar · ClinicalTrials.gg INT005470
- MeSH (NLM) C542437aleglitazarOne source NLM
- UNII (FDA) 41T4OAG59UALEGLITAZARConfirmed FDA, NLM, Wikidata
- Wikidata Q3609417aleglitazarConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72687AleglitazarOne source FDA
- DrugBank DB08915One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C542437 | aleglitazar | One source NLM |
| UNII (FDA) | 41T4OAG59U | ALEGLITAZAR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3609417 | aleglitazar | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72687 | Aleglitazar | One source FDA |
| DrugBank | DB08915 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.